Souhaitez-vous accéder aux communiqués récents ?

New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater...

WASHINGTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Security 2.0, Inc., an AI Consultancy, today announced it has been awarded an Indefinite Delivery / Indefinite Quantity (IDIQ) contract by the U.S....

RTI Awarded Position on MDA SHIELD IDIQ Contract

Adapt Forward has been selected by the Missile Defense Agency (MDA) to compete for task orders under the SHIELD contract.

Marotta Controls secures contract with L3Harris for thrust vector control system development, expanding Marotta’s product portfolio into new market sector

Dozens of cleaners, including workers at Abbotsford International Airport, may be going on strike. Members of SEIU Local 2, employed by Dexterra Group.

LONDON and VANCOUVER, British Columbia, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Mkango Resources Ltd (AIM/TSX-V: MKA) (the “Company” or “Mkango”) is pleased to announce that it has published its inaugural...

AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American License to Commercialize AGAMREE (vamorolone) for...

Vamorolone is a Promising Best-In-Class Dissociative Anti-Inflammatory Steroid Treatment for Duchenne Muscular Dystrophy Synergistic Novel Asset Leverages Catalyst's Expertise and Bolsters...